Innoviva Q2 EPS $0.02 Misses $0.26 Estimate, Sales $80.99M Beat $67.92M Estimate
Portfolio Pulse from Benzinga Newsdesk
Innoviva reported Q2 earnings of $0.02 per share, missing the analyst consensus estimate of $0.26 by 92.31%. The company's quarterly sales were $62.27 million, missing the estimate of $67.92 million by 8.33%. This represents a 60% decrease in earnings and a 42.46% decrease in sales compared to the same period last year.
August 04, 2023 | 12:24 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Innoviva's Q2 earnings and sales fell short of estimates, indicating a potential negative impact on its stock.
Innoviva's Q2 earnings and sales missed analyst estimates by significant margins, which could lead to a decrease in investor confidence and a potential drop in the stock price.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100